Looking far ahead

Probionova aims at taking probiotics to the next level. Our goal is to develop clinical evidence-based probiotics with pharmaceutical-grade production volumes for therapeutic applications.

Probionova relies on its leading scientific standing in the research and development of new probiotics in unprecedented or nearly unexplored fields, by investigating their  therapeutic potential.

We strongly believe that biology will be the next great revolution in the pharmaceutical sector, further moving new drug R&D away from chemical-synthesis APIs to biological therapeutic agents.

Research on human microbiome proved that our health and sickness conditions are closely linked to our gut microbes. As a consequence, Probionova decided to make large investments in the probiotic sector, firmly believing in their active contribution to the development of new-generation medications.